Search results
Results from the WOW.Com Content Network
A similar procedure is transarterial embolization but without chemotherapeutic agents injection, used in the treatment of hypervascular liver metastases. These therapies are based on the predominantly arterial vasculature of HCC and hypervascular metastases, while the remaining liver parenchyma has a dual vascular intake, predominantly portal.
There are also liver cancer specific staging systems, each of which has treatment options that may result in a non recurrence of cancer, or cure. [57] [58] [59] For example, for HCC it is common to use the Barcelona Clinic Liver Cancer Staging System. [39] Treatments include surgery, medications, and ablation methods.
Treatment of hepatomegaly varies with the cause, so accurate diagnosis is the first concern. In auto-immune liver disease, prednisone and azathioprine may be used for treatment. [3] In lymphoma the treatment options include single-agent (or multi-agent) chemotherapy and regional
Tissues that have higher echogenicity are called "hyperechoic" and are usually represented with lighter colors on images in medical ultrasonography. In contrast, tissues with lower echogenicity are called "hypoechoic" and are usually represented with darker colors.
Chronic liver disease takes several years to develop and the condition may not be recognised unless there is clinical awareness of subtle signs and investigation of abnormal liver function tests. Testing for chronic liver disease involves blood tests, imaging including ultrasound, and a biopsy of the liver. The liver biopsy is a simple ...
A cavernous liver hemangioma or hepatic hemangioma is a benign tumor of the liver composed of large vascular spaces lined by monolayer hepatic endothelial cells. It is the most common benign liver tumour, and is usually asymptomatic and diagnosed incidentally on radiological imaging or during laparotomy for other intra-abdominal issues.
The Liver Injury Scale classification (2018 revision) [1] [2] [10] Grade Subcapsular hematoma Laceration Vascular injury I <10% surface area <1 cm in depth - II: 10–50% surface area: 1–3 cm - III >50% or >10 cm >3 cm Any injury in the presence of a liver vascular injury or active bleeding contained within liver parenchyma IV: 25–75% of a ...
The radiation sensitivity of the liver parenchyma limits the radiation dose that can be delivered via external beam radiotherapy. SIRT, on the other hand, involves the direct insertion of radioactive microspheres to a region, resulting in a local and targeted deposition of radioactive dose. It is therefore well-suited for treatment of liver tumors.